Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.
We are pleased to achieve this important milestone and remain vigilant as we work to continuously improve everything we do on behalf of the patients and providers we serve.” About Outset Medical, Inc.
Outset Medical (OM) announced it has been notified by the FDA that all issues cited in a warning letter the company received in July of 2023 ...
Globus Medical, Inc. has a 12 month low of $49.33 and a 12 month high of $94.93. The stock has a fifty day simple moving average of $85.85 and a two-hundred day simple moving average of $77.36.
The burden of medical debt was just eliminated for another 20,000 New Jersey residents on Friday in the state’s third round of medical debt abolishment. Since last August, New Jersey and Undue ...
Globus Medical, Inc. (NYSE:GMED – Free Report) – Stock analysts at Roth Capital dropped their FY2024 earnings per share (EPS) estimates for shares of Globus Medical in a research note issued ...
AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Brave is the woman in a transparent heel bearing the human foot in all its anatomical nakedness. These are difficult shoes to make work (a sort of non-item anchoring an outfit to nothing), which ...
But a warning to those who are thinking of following suit: “The foot by itself [without a sock] in a shoe, plastic or not, provides a perfect milieu for fungal growth,” Dr Rock Positano, director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results